Please help with financial position

Novak Inc. follows IFRS and is adjusting and correcting its books at the end of 2023. In reviewing its records, the following information has been compiled: 1. In 2023, the depreciation method on plant assets should be changed from the sum-of-the-years-digits to the straight-line method due to a change in pattern of usage. The assets were purchased at the beginning of 2022 for $88,200 with an estimated useful life of four years and no residual value. Novak has already recorded 2023 depreciation expense of $26,460 related to the assets, using the sum-of-the-years'-digits method. 2. Ending inventory for 2022 was overstated by $19,600; ending inventory for 2023 is correctly stated. 3. The adjusted trial balance at December 31,2021 , includes the following amounts: Cash $37,240; Inventory $109,760; Accounts Payable $47,040; Retained Earnings $70,560. 4. Dividends of $29,400 and $24,500 were declared and paid on December 31,2023 , and December 31, 2022, respectively. 5. Share capital of $29,400 consists of 12,250 common shares outstanding since the company's inception. Novak's statement of financial position and income statement are as follows at December 31, 2022 and 2023, before any corrections related to the information above. The December 31,2023 statements are in draft form only and the 2023 accounts have not yet been closed. Prepare the comparative income statement for 2023. Ignore income tax effects. (Round earnings per share to 2 decimal places, e.g. 52.75.) Prepare the comparative statement of changes in equity for 2023. Ignore income tax effects. Prepare the comparative statement of financial position as at December 31,2023 . Ignore income tax effects. (List Assets in order of liquidity. Do not leave any answer field blank. Enter 0 for amounts.)